Patents by Inventor Ting-Ting Hong

Ting-Ting Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bin1 as a prognostic marker in cardiovascular disease
    Patent number: 9150924
    Abstract: The present disclosure provides methods involving use of BIN1 expression levels, in heart tissue, in evaluating the risk of a poor outcome in a patient diagnosed with congestive heart failure. The methods finds use in evaluating patients who are heart transplant candidates as well as in assessing therapy options and efficacy of treatment in congestive heart failure patients.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: October 6, 2015
    Assignee: The Regents of the University of California
    Inventors: Robin Shaw, Ting-Ting Hong, James Smyth
  • Body Fluid BIN1 as a Marker of Cardiac Health
    Publication number: 20150233947
    Abstract: The present disclosure provides methods involving use of BIN1 protein levels in biological fluid of a subject in evaluating cardiac health of the subject. The method provided herein may be used to predict a risk of a poor outcome in a subject. The methods also find use in evaluating subjects for assessing patients diagnosed with heart failure. These methods are also useful in assessing therapy options and efficacy of treatment in heart failure patients.
    Type: Application
    Filed: February 19, 2015
    Publication date: August 20, 2015
    Inventors: Robin Shaw, Ting-Ting Hong
  • Body fluid BIN1 as a marker of cardiac health
    Patent number: 8999659
    Abstract: The present disclosure provides methods involving use of BIN1 protein levels in biological fluid of a subject in evaluating cardiac health of the subject. The method provided herein may be used to predict a risk of a poor outcome in a subject. The methods also find use in evaluating subjects for assessing patients diagnosed with heart failure. These methods are also useful in assessing therapy options and efficacy of treatment in heart failure patients.
    Type: Grant
    Filed: October 20, 2011
    Date of Patent: April 7, 2015
    Assignee: The Regents of the University of California
    Inventors: Robin Shaw, Ting-Ting Hong
  • Bin1 as a Prognostic Marker in Cardiovascular Disease
    Publication number: 20140302502
    Abstract: The present disclosure provides methods involving use of BIN1 expression levels, in heart tissue, in evaluating the risk of a poor outcome in a patient diagnosed with congestive heart failure. The methods finds use in evaluating patients who are heart transplant candidates as well as in assessing therapy options and efficacy of treatment in congestive heart failure patients.
    Type: Application
    Filed: February 10, 2014
    Publication date: October 9, 2014
    Applicant: The Regents of the University of California
    Inventors: Robin Shaw, Ting-Ting Hong, James Smyth
  • Body Fluid BIN1 as a Marker of Cardiac Health
    Publication number: 20130266975
    Abstract: The present disclosure provides methods involving use of BIN1 protein levels in biological fluid of a subject in evaluating cardiac health of the subject. The method provided herein may be used to predict a risk of a poor outcome in a subject. The methods also find use in evaluating subjects for assessing patients diagnosed with heart failure. These methods are also useful in assessing therapy options and efficacy of treatment in heart failure patients.
    Type: Application
    Filed: October 20, 2011
    Publication date: October 10, 2013
    Applicant: The Regents of the University of California
    Inventors: Robin Shaw, Ting-Ting Hong
  • Bin1 as a Prognostic Marker in Cardiovascular Disease
    Publication number: 20120094300
    Abstract: The present disclosure provides methods involving use of BIN1 expression levels, in heart tissue, in evaluating the risk of a poor outcome in a patient diagnosed with congestive heart failure. The methods finds use in evaluating patients who are heart transplant candidates as well as in assessing therapy options and efficacy of treatment in congestive heart failure patients.
    Type: Application
    Filed: April 23, 2010
    Publication date: April 19, 2012
    Inventors: Robin Shaw, Ting-Ting Hong, James Smyth